Samuel P. Baldwin

642 total citations
8 papers, 525 citations indexed

About

Samuel P. Baldwin is a scholar working on Molecular Biology, Biomedical Engineering and Cellular and Molecular Neuroscience. According to data from OpenAlex, Samuel P. Baldwin has authored 8 papers receiving a total of 525 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Biomedical Engineering and 2 papers in Cellular and Molecular Neuroscience. Recurrent topics in Samuel P. Baldwin's work include Neuroscience and Neural Engineering (2 papers), Innovative Microfluidic and Catalytic Techniques Innovation (1 paper) and Chemical Synthesis and Analysis (1 paper). Samuel P. Baldwin is often cited by papers focused on Neuroscience and Neural Engineering (2 papers), Innovative Microfluidic and Catalytic Techniques Innovation (1 paper) and Chemical Synthesis and Analysis (1 paper). Samuel P. Baldwin collaborates with scholars based in United States and United Kingdom. Samuel P. Baldwin's co-authors include W. Mark Saltzman, John M. Maloney, N. Sheppard, Jonathan Coppeta, John T. Santini, Mark Staples, Christine E. Krewson, Nadya Belcheva, Guy Whitley and Angela Clerk and has published in prestigious journals such as Nature Biotechnology, Advanced Drug Delivery Reviews and Tissue Engineering.

In The Last Decade

Samuel P. Baldwin

8 papers receiving 501 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Samuel P. Baldwin United States 7 285 193 97 74 57 8 525
Yixuan Shang China 12 455 1.6× 165 0.9× 67 0.7× 104 1.4× 74 1.3× 22 799
Christoph Tondera Germany 10 286 1.0× 118 0.6× 104 1.1× 70 0.9× 69 1.2× 14 531
Jen‐Hung Fang Taiwan 10 351 1.2× 274 1.4× 88 0.9× 136 1.8× 31 0.5× 13 612
Dongyu Xu China 17 428 1.5× 171 0.9× 112 1.2× 112 1.5× 79 1.4× 33 802
Qianru Jin United States 13 583 2.0× 132 0.7× 86 0.9× 95 1.3× 93 1.6× 23 880
Xiaoxuan Tang China 19 230 0.8× 222 1.2× 101 1.0× 72 1.0× 77 1.4× 36 780
C. Vodouhé France 10 157 0.6× 159 0.8× 42 0.4× 30 0.4× 47 0.8× 16 435
Ashlyn T. Young United States 11 280 1.0× 121 0.6× 81 0.8× 90 1.2× 68 1.2× 17 475
Hyunsik Choi South Korea 14 481 1.7× 104 0.5× 64 0.7× 63 0.9× 31 0.5× 26 747
Ludovic Serex Switzerland 9 417 1.5× 224 1.2× 72 0.7× 40 0.5× 87 1.5× 10 621

Countries citing papers authored by Samuel P. Baldwin

Since Specialization
Citations

This map shows the geographic impact of Samuel P. Baldwin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samuel P. Baldwin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samuel P. Baldwin more than expected).

Fields of papers citing papers by Samuel P. Baldwin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samuel P. Baldwin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samuel P. Baldwin. The network helps show where Samuel P. Baldwin may publish in the future.

Co-authorship network of co-authors of Samuel P. Baldwin

This figure shows the co-authorship network connecting the top 25 collaborators of Samuel P. Baldwin. A scholar is included among the top collaborators of Samuel P. Baldwin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samuel P. Baldwin. Samuel P. Baldwin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Baldwin, Samuel P., et al.. (2021). BS23 mRNA expression profiling of dual specificity phosphatases (DUSPS) in the hypertensive heart. A169.1–A169. 1 indexed citations
2.
Baldwin, Samuel P., N. Sheppard, John M. Maloney, et al.. (2006). Chronic, programmed polypeptide delivery from an implanted, multireservoir microchip device. Nature Biotechnology. 24(4). 437–438. 170 indexed citations
3.
Maloney, John M., et al.. (2005). In Vivo Biostability of CVD Silicon Oxide and Silicon Nitride Films. MRS Proceedings. 872. 27 indexed citations
4.
Baldwin, Samuel P. & W. Mark Saltzman. (2001). Aggregation Enhances Catecholamine Secretion in Cultured Cells. Tissue Engineering. 7(2). 179–190. 18 indexed citations
5.
Belcheva, Nadya, Samuel P. Baldwin, & W. Mark Saltzman. (1998). Synthesis and characterization of polymer-(multi)-peptide conjugates for control of specific cell aggregation. Journal of Biomaterials Science Polymer Edition. 9(3). 207–226. 28 indexed citations
6.
Baldwin, Samuel P. & W. Mark Saltzman. (1998). Materials for protein delivery in tissue engineering. Advanced Drug Delivery Reviews. 33(1-2). 71–86. 196 indexed citations
7.
Baldwin, Samuel P. & W. Mark Saltzman. (1996). Polymers for tissue engineering. 4(4). 177–182. 30 indexed citations
8.
Baldwin, Samuel P., Christine E. Krewson, & W. Mark Saltzman. (1996). PC12 CELL AGGREGATION AND NEURITE GROWTH IN GELS OF COLLAGEN, LAMININ AND FIBRONECTIN. International Journal of Developmental Neuroscience. 14(3). 351–364. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026